COMPASS PathwaysLONDON, Aug. 04, 2022 --Highlights:Kabir Nath appointed as Chief Executive Officer Phase III program submitted to FDA and under reviewCOMP360 phase II study in anorexia nervosa launchedCash position at 30 June 2022 of $207.2 millionConference call today at 8:00am ET (1:00pm UK)COMPASS Pathways plc (Nasdaq: CMPS) (โCOMPASSโ... Read More...
โย Fieldย Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022. โย Field Trip Discovery to be renamed Reunion Neuroscience Inc., remaining listed on the NASDAQ Stock Market and Toronto Stock Exchange. TORONTO, Aug. 04, 2022 -- Field Trip Health Ltd. (TSX:... Read More...
VANCOUVER, BC, July 29, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units (the "Units") at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022 (the "Clo... Read More...
VANCOUVER, British Columbia, July 29, 2022 -- HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Companyโ or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it will complete a consolidation (โConsolida... Read More...
Silo shows reversal of allodynia and hyperalgesia using its selected formulation and partnered, patented delivery system ENGLEWOOD CLIFFS, N.J, July 27, 2022 -- Silo Pharma, Incย . (OTCQB: SILO), a development-stage biopharmaceutical company today announced that its topically administered Ketamine reached a positive end point in an animal ... Read More...
COMPASS PathwaysLONDON, July 26, 2022 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2022, and provide an update on recent business developments on 4 Au... Read More...
Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATOยฎ to Minneapolis, Salt Lake City, Dallas with More Locations Soon
KWC, Serving the Most Patients in the U.S., Adds NAD+ Therapy and Launches Ketamine Wellness Integrated Therapist Directory
VANCOUVER, BC, July 21, 2022 -ย Delic Holdings Corp ("DELI... Read More...
- First Dosings completed in Australia- Provides Update on Pending Spin-Out and Renaming to Reunion Neurosciences- Announces 5:1 Share Consolidation Ratio TORONTO, July 21, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" or the โCompanyโ), a global leader in the development and delivery of psychedelic thera... Read More...
ReutersFactory shutdown to hit Barry Callebaut after 9-month sales riseZURICH (Reuters) -Barry Callebaut expects a "notable financial impact" in its fourth quarter from the shutdown of its Wieze factory as the world's biggest chocolate maker said on Wednesday that strong demand boosted sales in the nine months to May. Sales volumes grew 7... Read More...
ReutersCryptoverse: Holding your breath for a bitcoin bounceBitcoin's slide since May, swamped by economic angst, has knocked it below its 200-week moving average, at around $22,600, as well as its 200-day moving average around $35,500. Valkyrie Investments, for one, says its research is pointing to an upside move - but that it isn't clea... Read More...
ReutersCryptoverse: Holding your breath for a bitcoin bounceBitcoin's slide since May, swamped by economic angst, has knocked it below its 200-week moving average, at around $22,600, as well as its 200-day moving average around $35,500. Valkyrie Investments, for one, says its research is pointing to an upside move - but that it isn't clea... Read More...
Under Dr. Roggen's leadership, Delic Labs will transfer their expertise and experience from the cannabis sector to establish itselfย as the leader in psychedelic research and safety testing. The lab has received Health Canada 56 exemptions for chemistry analytics on psilocybin mushrooms; to perform research and tests on a host of compound... Read More...
Revenues grew 32% year-over-year to $0.74 million for the quarter
Clinic network revenues grew 59.5% from the same quarter last year and 7.5% compared to prior quarter
Achieved 24.4% gross margin and $180,845 gross profit of during Q3 2022
Ended quarter with strong cash position of $41.8 million
Completed acquisition of Novamind, posit... Read More...
KELOWNA, British Columbia, July 14, 2022 -- Allied Corp. ("Allied" or the โCompanyโ) (OTCQB: ALID) is pleased to announce that it has completed its second shipment of commercial dried cannabis from Colombia to an international market. On April 01, 2022 Colombia enacted the new legislation allowing for the legal export of dried cannabis pr... Read More...
VANCOUVER, British Columbia, July 13, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (โOptimiโ or the โCompanyโ), a homegrown, Canadian company cultivating and synthesizing high quality psychedelics and natural functional and psilocybin mushroom strains for transformational human experiences, is pleased to announce that... Read More...
ENGLEWOOD CLIFFS, N.J, July 12, 2022 -- Silo Pharma, Incย . (OTCQB: SILO), a development-stage biopharmaceutical company today announces that its novel liposomes reached a positive endpoint in animal studies showing effectiveness and reduced toxicity using a subcutaneous delivery method. Eric Weisblum, CEO of Silo Pharma commented โThe suc... Read More...
-- Expected to accelerate clinical development pathway of CYB004 for the potential treatment of anxiety disorders by nine months --TORONTO, July 11, 2022--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to Therapeuticsโข", today announc... Read More...
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe"), a Canadian Biotechnology company committed to discovering and developing psychedelic derived medicines today announced it has developed its initial Phase 1 study plan intended to demonstrate the safety and appropriate dos... Read More...
VANCOUVER, British Columbia, July 07, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (โPure Extractsโ or the โCompanyโ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to provide a brief summary of recent activities. The Summer season has... Read More...
VANCOUVER, British Columbia, July 07, 2022 -- Algernon Pharmaceuticals Inc.ย (the โCompanyโ or โAlgernonโ) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on its planned Phase 1 clinical human study of AP-188 (โN,N-dimethyltryptamineโ or โDMTโ). DMT ... Read More...
VANCOUVER, British Columbia, July 05, 2022 -- Algernon Pharmaceuticals Inc.ย (the โCompanyโ or โAlgernonโ) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to disclose that as part of its intellectual property patent applications filed in early 2021 for AP-188 (โN,N-dimethyltryptami... Read More...
Toronto, Ontario--(Newsfile Corp. - June 30, 2022) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has sold four patent applications and all associated supporting data to Apollon Formularies PLC ("Apollon"), a UK based international pharmaceutical company listed for trading on the Aquis St... Read More...
VANCOUVER, British Columbia, June 30, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (โPure Extractsโ or the โCompanyโ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pure Extracts Manufactur... Read More...
Nation's Largest Ketamine Therapy Provider Offers Complimentary Patient Resource Supporting Holistic Mental Health Treatment
GILBERT, Ariz., June 30, 2022 - Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), today offic... Read More...
Completed strategic review and announced intention to separate the Field Trip Discovery and Field Trip Health divisions into two independent public companies.Earned patient services revenues of $1.7 million in fiscal fourth quarter, an increase of 26.7% over the prior quarter and 228% year over year. Full year patient services revenue was... Read More...
- Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange.- Closing of the arrangement expected to occur in August.- Also announces closing of subscription receipt offering. TORONTO, June 29, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" ... Read More...
KELOWNA, British Columbia, June 29, 2022 -- Allied Corp. ("Allied" or the โCompanyโ) (OTCQB: ALID) is pleased to announce that it has completed the first shipment of commercial dried cannabis from Colombia to an international market. On April 01, 2022 Colombia enacted the new legislation allowing for the legal export of dried cannabis pro... Read More...
โ Red Light Holland launches: 'Red Light. Set. Go!' program to work with exceptional local Oregonians from diverse backgrounds who wish to enter the legal psilocybin service market.โ Shunji Smith, Japanese American avid mushroom grower, teacher, and small business owner from Eugene, Oregon joins the program.โ Red Light Holland and Halo Co... Read More...
Optimi Health Corp.Optimi Health Cultivation and Analytical FacilitiesOptimi Health Cultivation and Analytical FacilitiesOptimi Health Fruiting RoomOptimi Health fruiting room being prepared for second grow.VANCOUVER, British Columbia, June 28, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (โOptimiโ or the โCompanyโ), ... Read More...
VANCOUVER, British Columbia, June 28, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (โPure Extractsโ or the โCompanyโ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pu... Read More...
TORONTO, June 27, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" or "Corporation"), a global leader in the development and delivery of psychedelic therapies, today announced that on June 27, 2022, its shareholders approved both the Arrangement Resolution, the Concurrent Financing Resolution and the SpinCo ... Read More...
New branding unifies Numinus' presence across North America
Rebranding will be accomplished in phases and completed by end of 2022
VANCOUVER, BC, June 27, 2022 - Numinus Wellness Inc. ("Numinus", the "Company") (TSX: NUMI) (OTCQX: NUMIF) is pleased to announce the launch of a new visual brand identity that will be applied to all Company ... Read More...
VANCOUVER, British Columbia, June 27, 2022 -- Bright Minds Biosciences (โBright Minds,โ โBMBโ or the โCompanyโ) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Dr. Alan Kozikowski will no longer serve in... Read More...
Silo Enters into Commercial Evaluation License Agreement for Next Generation Liposomes Therapeutics Would Target Multiple Diseases Including Auto Immune Disorders ENGLEWOOD CLIFFS, N.J., June 23, 2022 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of traditional and psychedelics as a t... Read More...
June 27, 2022Held at the Lotte New York Palace Hotel, the inaugural event will feature a full day of company presentations, networking opportunities and one-on-one investor meetings with a focus on neuropsychiatry, psychedelics and more. During this year's conference, Stang will deliver a presentation that highlights the company's strateg... Read More...
VANCOUVER, British Columbia, June 23, 2022 -- BetterLife Pharma Inc. (โBetterLifeโ or the โCompanyโ) (CSE: BETR /ย OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that Dr. Ahmad Doroudian, Chief Executive Officer, will p... Read More...
TORONTO, June 23, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Tripโs Co-founder and Executive Chairman, Ronan Levy, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in a live fireside ... Read More...
TORONTO, June 22, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal fourth quarter and full year ended March 31, 2022, after market close on Wednesday, June 29,... Read More...
The segment includes an in-depth interview with HAVN Life CEO, Tim Moore, as well as clips from Chief Psychedelic Officer, Dr. Ivan Casselman, and Chief Research Officer, Alexzander Samuelsson, where they discuss the Company's end-to-end research, extraction, formulation, and delivery of naturally derived psilocybin, and some of the stra... Read More...
Filing would offer added protection to IP already submitted to USPTO
VANCOUVER, BC, June 22, 2022 - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that its subsidiary Numinus Bioscience Inc. ... Read More...